 Process GO Term   molting cycle    And related genes <body> Process GO Term molting cycle  and related genes   Total 2409 
Page number 38 * 	  Previous Page   *  Next Page    1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10   |   11   |   12   |   13   |   14   |   15   |   16   |   17   |   18   |   19   |   20   |   21   |   22   |   23   |   24   |   25   |   26   |   27   |   28   |   29   |   30   |   31   |   32   |   33   |   34   |   35   |   36   |   37   |   38   |   39   |   40   |   41   |   42   |   43   |   44   |   45   |   46   |   47   |   48   |   49   |   50   |   51   |   52   |   53   |   54   |   55   |   56   |   57   |   58   |   59   |   60   |   61   |   62   |   63   |   64   |   65   |   66   |   67   |   68   |   69   |   70   |   71   |   72   |   73   |   74   |   75   |   76   |   77   |   78   |   79   |   80   |   81  
    Gene Name  ORF Name  Function GO Term   Process GO Term   Component GO Term  Interacting Genes  Description  Gene Product  Phenotype     NAM7   YMR080C  ATPase activity*   mRNA catabolism*   cytoplasm*  YHR170W	YJR132W	YMR080C	YLR363C	YJL124C	YNL016W	YDL147W	YBR143C	YNL112W	YNL118C	YDR363W	  Involved in mRNA degradation  helicase (putative)  Null mutant is viable, exhibits impairment in respiratory growth that is exacerbated by low temperat     NAM8   YHR086W  RNA binding*   nuclear mRNA splicing, via spliceosome*   snRNP U1*  YIL061C	YDR432W	YLR249W	YBR119W	YLR275W	YDR240C	YGR013W	YMR125W	YGL049C	YDL043C	YER029C	YLR147C	YKL173W	YML046W	YKL012W	YDR235W	YLR298C	YPL178W	YDL087C	YGL181W	YMR257C	  May be non-essent. part of mito. splicing. Assoc. with spliceosomal snRNPs. Disp. for mitosis &amp; prem  RNA-binding protein|U1 snRNP protein|involved in meiosis-specific splicing of the REC107 transcripts  Null mutant is viable; defective in meiotic recombination, formation of viable spores, and formation     NAM9   YNL137C  structural constituent of ribosome   protein biosynthesis   mitochondrial small ribosomal subunit  YHL004W	YBR251W	YDR036C	  putative mitochondrial S4 ribosomal protein  mitochondrial S4 ribosomal protein (putative)  Null mutant is viable but is respiration-deficient and loses mitochondrial DNA integrity     NAN1   YPL126W  snoRNA binding   processing of 20S pre-rRNA   small nucleolar ribonucleoprotein complex  YDL072C	YER047C	YHR183W	YGR256W	YCL059C	YLR196W	YCR057C	YGR090W	YJL069C	YHR196W	YDL043C	  part of small (ribosomal) subunit (SSU) processosome (contains U3 snoRNA); Net1-Associated Nucleolar  U3 snoRNP protein  Null mutant is inviable     NAP1   YKR048C  protein binding   nucleosome assembly*   nucleus  YOL070C	YNL078W	YOL012C	YDR507C	YIL094C	YDR381W	YGL241W	YJR045C	YCL024W	YDR225W	YBL002W	YGR245C	YDR034C	YDR259C	YLR347C	YPL150W	YKL095W	YOR276W	YOL115W	YGR040W	YMR139W	YBR203W	YPR119W	YNL271C	YDR002W	  nucleosome assembly protein I  nucleosome assembly protein I  Null mutant is viable but exhibits defects in Clb2 function.     NAS2   YIL007C  molecular_function unknown   ubiquitin-dependent protein catabolism   cytoplasm  YKL212W	YDL020C	YOR117W	YLR304C	YHR185C	YMR200W	  Protein with similarity to the p27 subunit of mammalian proteasome modulator    Null mutant is viable and has no detectable phenotype     NAS6   YGR232W  molecular_function unknown   proteolysis and peptidolysis   proteasome regulatory particle (sensu Eukarya)  YHR200W	YDR088C	YPR086W	YNL244C	YGL004C	YDR394W	  Interaction with the 19S regulatory particle of the 26S proteasome detected by coimmunoprecipitation  26S proteasome interacting protein  Null mutant is viable.     NAT1   YDL040C  peptide alpha-N-acetyltransferase activity   protein amino acid acetylation   cytoplasm*  YMR116C	YHR013C	YAL009W	YML058W	  Required for entry into stationary phase, heat shock-resistance, a mating-type functions, and sporul  N-terminal acetyltransferase  Null mutant is viable, has reduced acetyltransferase activity, derepressed silent mating type locus     NAT2   YGR147C  peptide alpha-N-acetyltransferase activity   N-terminal peptidyl-methionine acetylation   cytoplasm    Transfers acetyl group from acetyl coenzyme A to the N-termini of proteins beginning with methionine  N alpha-acetyltransferase  Null mutant is inviable     NAT3   YPR131C  peptide alpha-N-acetyltransferase activity   N-terminal peptidyl-methionine acetylation   cellular_component unknown    Catalytic subunit of the NatB N-terminal acetyltransferase, which catalyzes acetylation of the amino  N-terminal acetyltransferase  Lack of N-terminal acetylation of proteins with Met-Glu-, Met-Asp- and certain other termini.     NAT5   YOR253W  peptide alpha-N-acetyltransferase activity   protein amino acid acetylation   cytoplasm      N-acetyltransferase       NCA2   YPR155C  molecular_function unknown   aerobic respiration*   cellular_component unknown  YBR162C	YPR086W	  Regulates proper expression of subunits 6 (Atp6p) and 8 (Atp8p) of the Fo-F1 ATP synthase    Null mutant is viable     NCB2   YDR397C  transcription co-repressor activity   negative regulation of transcription from Pol II promoter   nucleus  YER159C	  Negative Cofactor B2 is the beta subunit of a negative regulator of RNA polymerase II holoenzyme. It    Null mutant is inviable     NCL1   YBL024W  tRNA (cytosine-5-)-methyltransferase activity   tRNA methylation   nucleus  YGR237C	YBR084W	YDR382W	YNL284C	YLR200W	YGR078C	YNL153C	YEL003W	YML094W	  Nuclear protein 1, similar to NOP2 and human proliferation associated nucleolar protein p120  tRNA:m5C-methyltransferase  Null mutant is viable, sensitive to paromomycin, lacks m5C methylation in total yeast tRNA     NCP1   YHR042W  electron transporter activity   ergosterol biosynthesis   microsome    NADP-cytochrome P450 reductase  NADP-cytochrome P450 reductase       NDC1   YML031W  structural constituent of cytoskeleton   protein-nucleus import*   nuclear pore*  YOR284W	YMR153W	YGR010W	YDL088C	  dispensable for mitotic spindle pole body duplication, but required for insertion of nascent spindle  multiple transmembrane domains (putative)|nuclear envelope protein|nuclear pore complex subunit  Null mutant is inviable. Conditional lethal mutants are available that show asymmetric chromosomal s     NDD1   YOR372C  transcriptional activator activity   G2/M-specific transcription in mitotic cell cycle   nucleus  YDL203C	  Nuclear Division Defective 1    Null mutant is inviable and arrests prior to nuclear division but after DNA replication; cells are l     NDE1   YMR145C  NADH dehydrogenase activity   ethanol fermentation*   mitochondrion  YBR017C	YDL047W	YKR026C	  Hypothetical ORF         NDE2   YDL085W  NADH dehydrogenase activity   ethanol fermentation*   mitochondrion  YGR139W	YDR034C	  Hypothetical ORF    Null mutant is viable     NDI1   YML120C  NADH dehydrogenase (ubiquinone) activity   mitochondrial electron transport, NADH to ubiquinone   respiratory chain complex I (sensu Eukarya)  YGR218W	  NADH dehydrogenase (ubiquinone)  NADH dehydrogenase (ubiquinone)       NGG1   YDR176W  transcription cofactor activity   histone acetylation*   SAGA complex  YCR041W	YJR080C	YDL239C	YOL148C	YBR081C	YHR099W	YLR423C	YDR448W	YIL144W	YCL010C	YGL112C	YPR086W	YGR252W	YPL254W	YDR392W	YDR457W	  Involved in glucose repression of GAL4p-regulated transcription  genetic and mutant analyses suggest that Ngg1p (Ada3p) is part of two transcriptional adaptor/HAT (h  Null mutant is viable, grows poorly on minimal media     NGL2   YMR285C  endoribonuclease activity   rRNA processing   intracellular  YJL203W	YPR110C	  correct 3'-end formation of 5.8S rRNA at site E is strictly dependent on Ngl2p.  RNase  Null mutant is viable.     NHP2   YDL208W  RNA binding   rRNA modification*   small nuclear ribonucleoprotein complex  YKL014C	YMR310C	YCL037C	YOR308C	YMR290C	YDL014W	YNL124W	YER029C	YKL173W	YOR206W	YMR049C	YJL109C	YLR175W	YBL074C	YPR178W	YLR409C	YJR091C	YDR386W	YHR089C	YHR072W-A	  HMG-like nuclear protein  HMG-like protein  Null mutant is inviable     NHP6A   YPR052C  chromatin binding   regulation of transcription from Pol II promoter*   nuclear chromatin    Homologous to mammalian high mobility group proteins 1 and 2; functions redundantly with the highly  11 kDa nonhistone chromosomal protein  Deleting both NHP6A and NHP6B gives temperature-sensitive yeast with morphological and cytoskeletal     NHP6B   YBR089C-A  chromatin binding   regulation of transcription from Pol II promoter*   nuclear chromatin  YKR001C	YPL235W	YAR007C	YJL026W	YNR003C	YMR125W	YOR110W	YOR304W	YBR245C	YGL133W	YOR116C	YFR037C	YPL082C	YIL126W	YFR013W	YLR033W	  Homologous to mammalian high mobility group proteins 1 and 2; functions redundantly with the highly  11 kDa nonhistone chromosomal protein  Deleting both NHP6A and NHP6B gives temperature-sensitive yeast with morphological and cytoskeletal     NIC96   YFR002W  structural molecule activity   mRNA-nucleus export*   nuclear pore  YGR120C	YMR153W	YGL172W	YGR119C	YML103C	YMR129W	YJL039C	YJL041W	  Part of complex at nuclear pore containing in addition NSP1p, NUP49p, and p54  96 kDa nucleoporin-interacting component|nuclear pore complex subunit  Null mutant is inviable     NIP1   YMR309C  translation initiation factor activity   translational initiation   cytoplasm*  YOR284W	YOR361C	YNL047C	YNL244C	YBR079C	YPR041W	YMR146C	YLR175W	YPR016C	YGL130W	YOR039W	YPL001W	YAL029C	YPR086W	YBR058C	YAL035W	YGL081W	YBR234C	YOL087C	  Protein required for nuclear import with some similarity to Nsr1p, another protein involved in nucle  translation initiation factor eIF3 subunit  Null mutant is inviable; nip1-1 is a temperature-sensitive mutant defective in nuclear transport     NIP7   YPL211W  molecular_function unknown   rRNA processing*   nucleolus*  YER006W	YAL007C	YDR060W	YKR081C	YHR066W	YJR083C	YNL226W	YGR103W	YOR080W	YOL108C	YNL061W	YGR014W	  Nip7p is required for 60S ribosome subunit biogenesis    Null mutant is inviable; in the temperature-sensitive mutant nip7-1, glycine 71 is replaced by aspar     NMA1   YLR328W  nicotinamide-nucleotide adenylyltransferase activity   nicotinamide adenine dinucleotide metabolism   cellular_component unknown  YLR328W	YLR332W	YDR034C	YLR347C	YML064C	YNL189W	YPL259C	YLR438W	YGR010W	  NAD(+) salvage pathway  nicotinamide/nicotinic acid mononucleotide adenylyltransferase  Null: viable. Other phenotypes: 2 or more copies increase rDNA and telomeric silencing     NMA2   YGR010W  nicotinate-nucleotide adenylyltransferase activity   nicotinamide adenine dinucleotide metabolism   nucleus  YLR328W	YGR010W	YNL218W	YML031W	YNL189W	YPL070W	YLR438W	  NAD(+) salvage pathway  nicotinamide/nicotinic acid mononucleotide adenylyltransferase  Null: viable. Other phenotypes: 2 or more copies increase rDNA and telomeric silencing   </body> 